The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2
The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2
Recruiting · NCT06523400 · Registry updated 2026-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Muscular Disorders, Atrophic, hereditary disease, inherited neurodegenerative disorder, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, myotonic dystrophy, myotonic syndrome, nervous system disorder, neurodegenerative disease, neuromuscular disease | Recruiting | Phase 3 | 2026-09-24 | NCT06523400 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Lupin Atlantis Holdings S.A. | 4 |
| Lupin Ltd. | 5 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Aarhus University Hospital | Aarhus | Denmark | 77 |
| Azienda Ospedaliera Universitaria Policlinico Tor Vergata | Rome | Italy | 4 |
| Laboratory for Muscle Diseases and Neuropathies | Leuven | Belgium | 2 |
| Ludug-Maximilians University | München | Germany | 2 |
| Saint George's University Hospitals NHS Foundation Trust | London | United Kingdom | 2 |
| University College Hospital | London | United Kingdom | 9 |
| University Hospital of Madrid | Madrid | Spain | 2 |